secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aura Biosciences, Inc. (AURA)
CIK:        0001501796
Form:       8-K
Filed at:   2024-06-21T23:59:59+00:00
Accession:  0001193125-24-165656
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aura Biosciences shareholders approve officer exculpation amendment, re-elect directors
--------------------------------------------------------------------------------

- Amendment to Tenth Amended Certificate limits officer liability per Delaware law; effective June 20, 2024.
- Directors Antony Mattessich (28.3M for) and Sapna Srivastava (31.9M for) re-elected as Class III directors.
- Ernst & Young ratified as independent auditor for FY 2024 with 38.7M votes for, 5,843 against.
- Charter amendment filed as Exhibit 3.1; all proposals passed with broker non-votes on first two items.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501796/000119312524165656/0001193125-24-165656-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501796/000119312524165656/d783830d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-165656

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer